Loading, please wait...
.webp&w=384&q=75){kind=logo}
Verifying...
Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
Hippocrates
Recently, the ERAS® Society published the 2026 update for ERAS gynecologic oncology guidelines. This consensus review serves as the third major iteration, building upon an extensive database search from 2018 to 2025. Furthermore, these protocols optimize perioperative care to enhance patient outcomes and surgical efficiency. Additionally, the guidelines provide a structured framework for multidisciplinary teams to standardize care. Consequently, gynecologic surgeons can utilize these evidence-based strategies to reduce hospital stays and minimize complications.
The updated evidence base focuses on several critical perioperative elements. Specifically, researchers reviewed meta-analyses and randomized controlled trials to ensure high-quality recommendations. Moreover, they utilized the GRADE system to assess the level of evidence for each protocol item. Because patient safety remains paramount, the guidelines emphasize pain management, glycemic control, and early mobilization. Ultimately, implementing these protocols requires a shift from traditional surgical dogma toward data-driven clinical practices.
Gynecologic surgeons should consider incorporating these consensus-based recommendations into their specific practice environments. However, achieving local consensus is essential for successful pathway design. Since the guidelines target optimal recovery, they address pre-operative, intra-operative, and post-operative phases of care. Therefore, clinicians must remain updated on these evolving standards to provide the highest quality of oncological surgery. Consistent adherence to these protocols significantly improves the patient experience and healthcare delivery efficiency.
The guidelines aim to provide a consensus for optimal perioperative care. They focus on reducing surgical stress, accelerating functional recovery, and improving overall outcomes for patients undergoing gynecologic cancer surgery.
This update incorporates the latest evidence from 2018 to 2025, specifically prioritizing meta-analyses and randomized trials. It further refines recommendations using the GRADE system to ensure clinicians apply the best available evidence in practice.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Nelson G et al. Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: 2026 update. Gynecol Oncol. 2026 Jun 05. doi: undefined. PMID: 42247726.
Wijk L et al. Enhanced Recovery After Surgery (ERAS) in Gynecologic Oncology. International Journal of Gynecological Cancer. 2022.
"
Link will be sent via SMS to your number.
The 2026 ERAS guidelines for gynecologic oncology offer updated, evidence-based perioperative care protocols to optimize patient recovery and surgical outco...
2 weeks back
Hantaviruses are evolving from localized rural diseases into a global public health threat driven by climate change. This article examines the importance of the One Health approach in Southeast Europe to manage rodent reservoirs and prevent zoonotic spillover as environmental conditions shift.
Today
A study on 294 women after the Kahramanmaras earthquake shows that death distress, especially death depression, significantly influences fertility intentions. Key factors include age, income, and trauma experience, highlighting the need for mental health support in post-disaster care.
Today
Recent research highlights mussel-inspired catechol-amine copolyether brushes as a breakthrough in antifouling. By achieving high grafting density and maintaining chemical integrity, these coatings effectively prevent biofilm formation on medical devices, offering a substrate-independent solution for clinicians.
Today
A randomized controlled trial compared static stretching and myofascial release for hamstring tightness in IT professionals. While both methods improved flexibility, myofascial release demonstrated superior results in range of motion and functional scores over a three-week treatment period.
Today
Recent research identifies miR-335-5p as a key regulator for redifferentiating BRAF-mutant thyroid cancers. Restoring this microRNA enhances iodine uptake and inhibits EMT pathways, potentially resensitizing tumors to radioiodine and improving kinase inhibitor outcomes for refractory patients.
Today